Cancer experts condemn cancer drug decision

NICE drops recommended use of cancer drug nivolumab

Related items from OnMedica

NHS cancer patients still denied treatments available in other countries
Brexit could bar child patients from cancer trials
75% of reappraised CDF drugs approved for NHS
Study shows huge global variation in cancer drug costs
Controversial new drug approval system unveiled

from OnMedica News http://ift.tt/2oU7QQT
via IFTTT

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s